Reading between the Lines: Direct-to-Consumer Advertising of Genetic Testing
- 1 May 2001
- journal article
- Published by JSTOR in Hastings Center Report
- Vol. 31 (3) , 33-5
- https://doi.org/10.2307/3527555
Abstract
A case study in the kinds of problems to expect from this increasingly popular marketing tactic.Keywords
This publication has 21 references indexed in Scilit:
- Life Expectancy Gains From Cancer Prevention Strategies for Women With Breast Cancer and BRCA1 or BRCA2 MutationsJAMA, 2000
- Direct to consumer drug advertising is billion dollar business in USBMJ, 1999
- Hereditary Susceptibility to Breast Cancer: Significance of Age of Onset in Family History and Contribution of BRCA1 and BRCA2Disease Markers, 1999
- Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1The Lancet, 1998
- The Risk of Cancer Associated with Specific Mutations ofBRCA1andBRCA2among Ashkenazi JewsNew England Journal of Medicine, 1997
- Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium.1997
- Controlled Trial of Pretest Education Approaches to Enhance Informed Decision-Making for BRCA1 Gene TestingJNCI Journal of the National Cancer Institute, 1997
- Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996.Journal of Clinical Oncology, 1996
- Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.1995
- Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium.1993